Health Trials

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

ConditionsHuman Immunodeficiency Virus (HIV)Smoking Cessation
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorNew York University

About this trial

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Eligibility criteria

Qualifiers

Status as HIV+

Age 18 or older

Currently smokes ≥ 5 CPD, on average, in past month

Positive for salivary cotinine

Disqualifiers

Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy

Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion)

Currently participating in a smoking cessation program

Pregnant or nursing and plans to be in next 6 months

Trial design

Treatments tested in this trial

  • Motivational Interviewing (MI) Counseling
  • Peer Mentoring
  • Skills-based Text Messaging
  • Combination NRT

Treatment groups

500 Participants
are divided into 16 treatment groups

16

Treatment groups

See each treatment group below.

Sponsors and collaborators

New York University

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov